Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Calliditas: The European CHMP opinion is a timely value trigger

2022-05-20

08:26

JU

Johan Unnerus

The positive CHMP opinion is both timely and expected. The next step is a Q3 European approval allowing Calliditas partner Stada to launch Kinpeygo in Europe. We can also look forward to the Part B readout in early 2023, which is likely to support both sales and the process of converting the conditional approval to unconditional approval.

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers